-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Minimed Group, Lowers Price Target to $20

Benzinga·11/13/2026 15:36:05
Listen to the news
Barclays analyst Christopher Pasquale maintains Minimed Group (NASDAQ:MMED) with a Equal-Weight and lowers the price target from $22 to $20.